GLP Research Finds More People Use These Drugs for Weight Loss Than Health Conditions
Weight loss leads reported use
The research found that weight management has overtaken diabetes and other medical uses among Americans taking GLP-1 drugs. Those medications were originally prescribed for conditions including diabetes. The survey was conducted by strategy consulting firm EY-Parthenon and included nearly 15,000 people. Of those, 3,602 were current or former GLP-1 users.
Shopping habits are changing
As more consumers use the drugs to manage weight, some are changing what they eat and how they shop. Food manufacturers, grocery chains and other retailers are responding to those changes.
Johnson said that people who lose substantial weight while taking the drugs may need to shop differently. The article did not provide Johnson’s first name or role.
Access and forms expand
EY-Parthenon said GLP-1 drugs are reaching a broader group of consumers, contributing to increased use for weight loss. The research points to availability in more forms, including pills, and improved affordability. The firm said these factors are bringing more younger, lower-income and male consumers into the user population.
Key points
- More Americans use GLP-1 drugs for weight loss than for diabetes and other health conditions, the research found.
- The survey covered nearly 15,000 people, including 3,602 current or former GLP-1 users.
- Food makers and retailers are adapting as consumers change their eating and shopping habits.
- Researchers at Wharton are studying whether GLP-1 drugs can deter risky financial decisions.